Viela Bio, Inc. Common Stock
VIE
VIE was delisted on the 12th of March, 2021.
60 hedge funds and large institutions have $725M invested in Viela Bio, Inc. Common Stock in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 33 increasing their positions, 15 reducing their positions, and 10 closing their positions.
120% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 15
8% less funds holding
Funds holding: 65 → 60 (-5)
33% less capital invested
Capital invested by funds: $1.09B → $725M (-$360M)
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$19.3M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.5M |
| 3 |
JP Morgan Chase
New York
|
+$6.98M |
| 4 |
American Century Companies
Kansas City,
Missouri
|
+$5.47M |
| 5 |
Millennium Management
New York
|
+$4.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$12M |
| 2 |
Goldman Sachs
New York
|
-$8M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$7.29M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.54M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.83M |
VIE Hedge Fund Activity: Q3 2020 in Review
60 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Viela Bio, Inc. Common Stock (VIE) for Q3 2020, worth a combined $725M — down 33% from $1.09B a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of VIE and 5 opened new positions — a net loss of 5 holders — while 15 trimmed existing stakes and 33 added.
The largest buyer was State Street, adding an estimated $19.3M. The largest seller was HHLR Advisors, cutting an estimated $12M.
- 60 institutional investors held Viela Bio, Inc. Common Stock (VIE) as of Q3 2020, down from 65 in Q2 2020.
- Funds reported $725M of Viela Bio, Inc. Common Stock stock for Q3 2020, down 33% quarter-over-quarter.
- 5 funds opened new Viela Bio, Inc. Common Stock positions in Q3 2020 and 10 closed out, a net change of -5 holders.
- The largest Viela Bio, Inc. Common Stock buyer in Q3 2020 was State Street, an estimated $19.3M added.
- The largest Viela Bio, Inc. Common Stock seller in Q3 2020 was HHLR Advisors, an estimated $12M sold.
Based on aggregated 13F filings for Q3 2020.